Thaindian News

Washington, Aug 25 (IANS) Scientists have uncovered how high cholesterol levels bring about bone loss, potentially opening the way to new approaches for treating osteoporosis.
Osteoporosis affects 10 million Americans, causing fragile bones and increasing the risk of fractures, curtailing independence and mobility.

Scientists have long recognized the relationship between high cholesterol and osteoporosis, but pinpointing the exact mechanism connecting the two has proved elusive.

“We’ve known that osteoporosis patients have higher cholesterol levels, more severe clogging of the heart arteries and increased risk of stroke,” said Rita Effros, professor of pathology at the David Geffen School of Medicine, University of California-LA (UCLA).

“We also knew that drugs that lower cholesterol reduce bone fractures, too,” she explained. “What we didn’t understand was why.”

Effros suspected a clue to the mystery involved oxidation — cell and tissue damage resulting from exposure of the fatty acids in cholesterol to molecules known as free radicals.

UCLA researchers focused on low-density lipoprotein (LDL), the so-called “bad” cholesterol. They examined how high levels of oxidized LDL affect bone and whether a type of immune cell called a T-cell plays a role in the process.

Using blood samples from healthy human volunteers, the team isolated the participants’ T-cells and cultured them in a dish.

Half of the T-cells were combined with normal LDL - the rest was combined with oxidized LDL. The scientists stimulated half of the T cells to mimic an immune response and left the other half alone.

“Lo and behold, both the resting and the activated T cells started churning out a chemical that stimulates cells whose sole purpose is to destroy bone,” said Effros. Called RANKL, the chemical is involved in immune response and bone physiology.

These findings were published in the PNAS Early Edition online.